Search Within

Terry Kheng Pak

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Clinical Pharmacy Specialists (7)
  2. Department of Medicine (7)
  3. Epidemiology and Biostatistics (7)
  4. Center for Hematologic Malignancies (4)
  5. Hematologic Malignancies, Division of (4)
  6. Lymphoma (4)

More Groups

People
  1. Andrea Levoir (4)
  2. Esther Drill (4)
  3. Michael Buege (4)
  4. Phuong Dao (4)
  5. Tim Peterson (4)
  6. Alexander Drilon (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (1)
Publications
  1. Blood (1)
  2. British Journal of Cancer (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. European Journal of Haematology (1)
  5. Hematological Oncology (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)
  6. Wiley Blackwell (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure
    Journal Article

    Buege, M. J.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Dao, P. H.; Matasar, M. J.
    European Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save